Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.15
$0.081.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.08% | -58.24% | -10.76% | 5.88% | -17.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 327.41% | 4,536.84% | -33.23% | -75.35% | 218.30% |
| Change in Net Operating Assets | -139.58% | 107.78% | 66.04% | 134.36% | -174.48% |
| Cash from Operations | -97.53% | -14.24% | -1.85% | 41.33% | -339.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 99.96% | -107.44% | -52.73% | 49.48% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.85% | 29,348.91% | -- | -100.00% | -43.56% |
| Cash from Financing | 34,963.99% | -99.93% | 68,562.95% | -101.70% | 4,637.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 579.68% | -103.89% | 2,909.25% | -214.82% | 304.30% |